Kotak Mahindra Mutual Fund Acquires Over 5% Stake in Molbio Diagnostics
Molbio Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 16 Oct 2026, 3:43 pm
Kotak Mahindra Mutual Fund Acquires Over 5% Stake in Molbio Diagnostics Kotak Mahindra Mutual Fund (KMMF) crossed the 5% regulatory threshold in Molbio Diagnostics Ltd on 8th Oct'26 through an open market transaction. KMMF acquired 570,000 equity shares, representing a 0.4946% stake in the company. Following this acquisition, KMMF鈥檚 total holding increased from 5,749,083 shares (4.9888%) to 6,319,083 equity shares, raising its aggregate shareholding and voting rights to 5.4834% of Molbio Diagnostics' total paid-up equity share capital.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
